4340 Duncan Avenue St. Louis, MO 63110 314-615-6355 info@biogenerator.org


BioGenerator News

BioGenerator Company Confluence Life Sciences Acquired By Aclaris Therapeutics

Aug 08, 2017

ST. LOUIS –BioGenerator’s largest investment in any single company is paying off for St. Louis. Confluence Life Sciences, Inc. has been acquired by Aclaris Therapeutics, Inc. (NASDAQ: ACRS) for the […]

Read More

BioGenerator Supported Startup Precision Virologics Receives Investment From Oncolys BioPharma

Mar 29, 2017

Precision Virologics, a startup based on technology from Washington University, was created with support from BioGenerator Grants and BioSTL Fundamentals.  BioGenerator Grant funding supported laboratory proof of concept, grant applications […]

Read More


Mar 28, 2017

BioGenerator portfolio company Benson Hill Biosystems secured a $25M Series B financing led by Prelude Ventures and Lewis & Clark Ventures.  Benson Hill Biosystems was recruited to St. Louis by BioGenerator, […]

Read More

BioGenerator Company Canopy Biosciences Charts Quick Path To Revenue

Mar 07, 2017

Biotech startup Canopy charts quick path to revenue BioGenerator company Canopy Biosciences was featured in David Nicklaus’ column in the St. Louis Post-Dispatch. The article features interviews with Ed Weinstein, co-founder and chief […]

Read More

BioGenerator Company MediBeacon Completes Successful Clinical Study

Mar 02, 2017

Expanded Multicenter Study in U.S. and Europe to Begin Fourth Quarter 2017 ST. LOUIS – MediBeacon Inc., a portfolio company within the Pansend Life Sciences platform of HC2 Holdings, Inc. […]

Read More

BioGenerator Company Adarza BioSystems Closes $17M Series C

Jan 19, 2017

ROCHESTER, NY and ST LOUIS, MO Adarza BioSystems, Inc., a leading next generation innovator in label-free, multiplex assays, announced today that it has closed a $17M Series C financing. Proceeds from […]

Read More

AstraZeneca acquires antithrombotic from BioGenerator Company APT Therapeutics

Jan 05, 2017

AstraZeneca and APT Therapeutics have signed a research collaboration, option, and asset deal focused on the development of APT’s lead human recombinant apyrase therapy, APT102, for the treatment of thrombotic […]

Read More

BioGenerator Company Tioma Therapeutics Raises $86M

Aug 16, 2016

Funding Includes Support of Clinical Development of Anti-CD47 Antibody Program in Multiple Cancer Immunotherapy Trials Executive Team Headed by Biotech Industry Veteran John Donovan St. Louis, MO and Brisbane, CA […]

Read More

BioGenerator Company MediBeacon Acquires Mannheim Pharma & Diagnostics

Jun 14, 2016

Technology enables kidney function measurement in preclinical applications St. LOUIS – June 8, 2016 – St. Louis-based MediBeacon™ Inc., maker of proprietary, non-invasive, real-time monitoring systems for kidney function, gastrointestinal […]

Read More

2015 BioGenerator Annual Report Release

May 19, 2016

Read about BioGenerator’s 2015 investments, support activities and portfolio companies updates.

Read More

Latest Tweets

Getting Started

Entrepreneurs Investors